Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q1 2024 (March 31)21holders
$1.03avg. 13F price*
At the end of Q1 2024, 21 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings. The largest holders were Magnetar Financial LLC ($844K), Deerfield Management Company, L.P. ($333K) and Polar Asset Management Partners Inc. ($286K).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q1 2024)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $73K |
| Exits | 3 | $252K |
Ownership 21 holders
| Magnetar Financial LLC | — | Reduce -12.8% | 767,163 | $844K |
| Deerfield Management Company, L.P. | — | No change | 333,333 | $333K |
| Polar Asset Management Partners Inc. | — | No change | 285,864 | $286K |
| Exos Asset Management LLC | — | — | 167,610 | $168K |
| Vestcor Inc | — | No change | 148,755 | $149K |
| MSD Partners, L.P. | — | No change | 133,333 | $133K |
| Wolverine Asset Management LLC | — | Add +13.1% | 117,290 | $117K |
| Bracebridge Capital, LLC | — | Reduce -6.0% | 92,880 | $93K |
| Walleye Capital LLC | — | Add +5.0% | 80,883 | $81K |
| Kim, LLC | — | Reduce -11.2% | 79,007 | $79K |
| Sequoia Financial Advisors, LLC | — | No change | 62,187 | $62K |
| Aristeia Capital, L.L.C. | — | No change | 53,561 | $59K |
| Cowen and Company, LLC | — | New | 50,424 | $50K |
| CastleKnight Management LP | — | No change | 46,371 | $46K |
| Walleye Trading LLC | — | Add +5.0% | 45,496 | $45K |
| Clear Street LLC | — | Reduce -18.3% | 41,169 | $41K |
| HRT Financial LP | — | Add +0.1% | 29,956 | $29K |
| B & T Capital Management DBA Alpha Capital Management | — | New | 22,222 | $22K |
| Foster Victor Wealth Advisors, LLC | — | Add +70.2% | 20,973 | $21K |
| Nomura Holdings Inc. | — | No change | 10,800 | $11K |
| Tower Research Capital LLC (TRC) | — | No change | 42 | $42 |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.